Crossmark

Effect of incretin therapies compared to pioglitazone and gliclazide in non-alcoholic fatty liver disease in diabetic patients not controlled on metformin alone: An observational, pilot study

Crossref DOI link: https://doi.org/10.1016/j.endoen.2016.05.008

Published Print: 2016-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García Díaz, Eduardo

Guagnozzi, Danila

Gutiérrez, Verónica

Mendoza, Carmen

Maza, Cristina

Larrañaga, Yulene

Perdomo, Dolores

Godoy, Teresa

Taleb, Ghalli
License Information

Text and Data Mining valid from 2016-05-01
More Information

This article is maintained by: Elsevier

Article Title: Effect of incretin therapies compared to pioglitazone and gliclazide in non-alcoholic fatty liver disease in diabetic patients not controlled on metformin alone: An observational, pilot study

Journal Title: Endocrinología y Nutrición (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endoen.2016.05.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endonu.2016.01.006

Content Type: article

Copyright: © 2016 SEEN. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below